Insider filing · AXSM
Mark E Saad
Director
profile →
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Mark E Saad sold $1.1M of Axsome Therapeutics (AXSM)
Executed Sep 5 2025, disclosed Sep 5 2025, the same day.
Value, as filed
$1.1M
9,127 sh × $125.07
Executed
Sep 5 2025
the trade date, as filed
Disclosed
Sep 5 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMark E Saad (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $6.2M of AXSM (37,577 sh across 2 lots, as filed), executed Dec 31 2025.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mark E Saad in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$6.2M37,577 sh across 2 lots
Exec Dec 31 2025
Filed Jan 2 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $1.0M
11,016 sh × $91.31
Exec Sep 11 2024
Filed Sep 11 2024 · 5:30 PM ET